References
温韬, 赵金垣. 中毒性肝损伤发病机制的研究动态[J]. 中国工业医学杂志, 2009, 22(6): 434-438.
Frenzel, C. and Teschke, R. (2016) Herbal Hepatotoxicity: Clinical Characteristics and Listing Compilation. International Journal of Molecular Sciences, 17, Article 588. >https://doi.org/10.3390/ijms17050588
Garcia-Cortes, M., Robles-Diaz, M., Stephens, C., Ortega-Alonso, A., Lucena, M.I. and Andrade, R.J. (2020) Drug Induced Liver Injury: An Update. Archives of Toxicology, 94, 3381-3407. >https://doi.org/10.1007/s00204-020-02885-1
Li, J., Guo, C. and Wu, J. (2020) Astaxanthin in Liver Health and Disease: A Potential Therapeutic Agent. Drug Design, Development and Therapy, 14, 2275-2285. >https://doi.org/10.2147/dddt.s230749
胡艺琪, 史瑞雅, 陈佳音, 等. 虾青素临床研究现状及其在特医食品开发中的应用前景[J]. 中国海洋药物, 2022, 41(4): 89-94.
余小元, 谢子健, 曹月琴, 等. 虾青素的主要来源物种——雨生红球藻[J]. 生物学通报, 2022, 57(2): 7-11.
Lorenz, R.T. and Cysewski, G.R. (2000) Commercial Potential for Haematococcus Microalgae as a Natural Source of Astaxanthin. Trends in Biotechnology, 18, 160-167. >https://doi.org/10.1016/s0167-7799(00)01433-5
Stachowiak, B. and Szulc, P. (2021) Astaxanthin for the Food Industry. Molecules, 26, Article 2666. >https://doi.org/10.3390/molecules26092666
Naguib, Y.M.A. (2000) Antioxidant Activities of Astaxanthin and Related Carotenoids. Journal of Agricultural and Food Chemistry, 48, 1150-1154. >https://doi.org/10.1021/jf991106k
Kohandel, Z., Farkhondeh, T., Aschner, M., Pourbagher-Shahri, A.M. and Samarghandian, S. (2022) Anti-Inflammatory Action of Astaxanthin and Its Use in the Treatment of Various Diseases. Biomedicine&Pharmacotherapy, 145, Article ID: 112179. >https://doi.org/10.1016/j.biopha.2021.112179
Nakagawa, K., Kiko, T., Miyazawa, T., Carpentero Burdeos, G., Kimura, F., Satoh, A., et al. (2011) Antioxidant Effect of Astaxanthin on Phospholipid Peroxidation in Human Erythrocytes. British Journal of Nutrition, 105, 1563-1571. >https://doi.org/10.1017/s0007114510005398
陆婵君, 郭艺, 胡可, 等. 虾青素调控Nrf2通路发挥心血管保护作用的研究进展[J]. 中国新药与临床杂志, 2023, 42(5): 284-288.
Li, H., Li, J., Hou, C., Li, J., Peng, H. and Wang, Q. (2020) The Effect of Astaxanthin on Inflammation in Hyperosmolarity of Experimental Dry Eye Model in Vitro and in Vivo. Experimental Eye Research, 197, Article ID: 108113. >https://doi.org/10.1016/j.exer.2020.108113
Cui, L., Xu, F., Wang, M., Li, L., Qiao, T., Cui, H., et al. (2019) Dietary Natural Astaxanthin at an Early Stage Inhibits N-Nitrosomethylbenzylamine-Induced Esophageal Cancer Oxidative Stress and Inflammation via Downregulation of NFκB and COX2 in F344 Rats. OncoTargets and Therapy, 12, 5087-5096. >https://doi.org/10.2147/ott.s197044
中华医学会, 中华医学会杂志社, 中华医学会消化病学分会, 中华医学会全科医学分会, 中华医学会《中华全科医师杂志》编辑委员会, 消化系统疾病基层诊疗指南编写专家组. 药物性肝损伤基层诊疗指南(2019年) [J].中华全科医师杂志, 2020, 19(10): 868-875.
章晨怡, 茹清静. 浅议“药毒”与药物性肝损伤[J]. 中西医结合肝病杂志, 2020, 30(2): 179-181.
朱蓉蓉, 谢治强, 马瑞萍. 药物性肝损伤研究现状[J]. 社区医学杂志, 2023, 21(10): 535-539.
卢伟, 潘梦, 方亦可, 等. 中药治疗急性肝损伤作用机制研究进展[J]. 中南药学, 2019, 17(9): 1504-1507.
Stravitz, R.T. and Lee, W.M. (2019) Acute Liver Failure. The Lancet, 394, 869-881. >https://doi.org/10.1016/s0140-6736(19)31894-x
Moles, A., Torres, S., Baulies, A., Garcia-Ruiz, C. and Fernandez-Checa, J.C. (2018) Mitochondrial-Lysosomal Axis in Acetaminophen Hepatotoxicity. Frontiers in Pharmacology, 9, Article 453. >https://doi.org/10.3389/fphar.2018.00453
da Rocha, B.A., Ritter, A.M.V., Ames, F.Q., Gonçalves, O.H., Leimann, F.V., Bracht, L., et al. (2017) Acetaminophen-induced Hepatotoxicity: Preventive Effect of Trans Anethole. Biomedicine&Pharmacotherapy, 86, 213-220. >https://doi.org/10.1016/j.biopha.2016.12.014
Yan, M., Huo, Y., Yin, S. and Hu, H. (2018) Mechanisms of Acetaminophen-Induced Liver Injury and Its Implications for Therapeutic Interventions. Redox Biology, 17, 274-283. >https://doi.org/10.1016/j.redox.2018.04.019
Jaeschke, H., Akakpo, J.Y., Umbaugh, D.S. and Ramachandran, A. (2020) Novel Therapeutic Approaches against Acetaminophen-Induced Liver Injury and Acute Liver Failure. Toxicological Sciences, 174, 159-167. >https://doi.org/10.1093/toxsci/kfaa002
Cai, X., Hua, S., Deng, J., Du, Z., Zhang, D., Liu, Z., et al. (2022) Astaxanthin Activated the Nrf2/HO-1 Pathway to Enhance Autophagy and Inhibit Ferroptosis, Ameliorating Acetaminophen-Induced Liver Injury. ACS Applied Materials&Interfaces, 14, 42887-42903. >https://doi.org/10.1021/acsami.2c10506
Mohan, M., Kamble, S., Gadhi, P. and Kasture, S. (2010) Protective Effect of Solanum Torvum on Doxorubicin-Induced Nephrotoxicity in Rats. Food and Chemical Toxicology, 48, 436-440. >https://doi.org/10.1016/j.fct.2009.10.042
Ma, H., Chen, S., Xiong, H., Wang, M., Hang, W., Zhu, X., et al. (2020) Astaxanthin from Haematococcus pluvialis Ameliorates the Chemotherapeutic Drug (Doxorubicin) Induced Liver Injury through the Keap1/Nrf2/HO-1 Pathway in Mice. Food&Function, 11, 4659-4671. >https://doi.org/10.1039/c9fo02429h
Belfayol-Pisanté, L., Guillevin, L., Tod, M. and Fauvelle, F. (2000) Pharmacokinetics of Cyclophosphamide (CP) and 4-OH-CP/aldophosphamide in Systemic Vasculitis. Fundamental&Clinical Pharmacology, 14, 415-421. >https://doi.org/10.1111/j.1472-8206.2000.tb00424.x
Zhong, S., Huang, M., Yang, X., Liang, L., Wang, Y., Romkes, M., et al. (2006) Relationship of Glutathione S-Transferase Genotypes with Side-effects of Pulsed Cyclophosphamide Therapy in Patients with Systemic Lupus Erythematosus. British Journal of Clinical Pharmacology, 62, 457-472. >https://doi.org/10.1111/j.1365-2125.2006.02690.x
Tripathi, D.N. and Jena, G.B. (2010) Astaxanthin Intervention Ameliorates Cyclophosphamide-Induced Oxidative Stress, DNA Damage and Early Hepatocarcinogenesis in Rat: Role of Nrf2, P53, P38 and Phase-Ii Enzymes. Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 696, 69-80. >https://doi.org/10.1016/j.mrgentox.2009.12.014
邓亮, 徐可树. 中毒性肝病诊治的相关问题[J]. 中国临床医生, 2014, 42(10): 14-17.
Ohta, Y., Kongo-Nishimura, M., Matsura, T., Yamada, K., Kitagawa, A. and Kishikawa, T. (2003) Melatonin Prevents Disruption of Hepatic Reactive Oxygen Species Metabolism in Rats Treated with Carbon Tetrachloride. Journal of Pineal Research, 36, 10-17. >https://doi.org/10.1046/j.1600-079x.2003.00091.x
Zhang, C., Han, C., Zhao, B. and Yu, H. (2012) The Protective Effects of Aqueous Extracts of Wild-Growing and Fermented Royal Sun Mushroom, Agaricus brasiliensis S. Wasser et al. (Higher Basidiomycetes), in CCl
4-Induced Oxidative Damage in Rats. International Journal of Medicinal Mushrooms, 14, 557-561. >https://doi.org/10.1615/intjmedmushr.v14.i6.30
Ohta, Y., Imai, Y., Matsura, T., Kitagawa, A. and Yamada, K. (2006) Preventive Effect of Neutropenia on Carbon Tetrachloride-Induced Hepatotoxicity in Rats. Journal of Applied Toxicology, 26, 178-186. >https://doi.org/10.1002/jat.1122
Kang, J.O., Kim, S.J. and Kim, H. (2001) Effect of Astaxanthin on the Hepatotoxicity, Lipid Peroxidation and Antioxidative Enzymes in the Liver of CCl
4-Treated Rats. Methods and Findings in Experimental and Clinical Pharmacology, 23, 79. >https://doi.org/10.1358/mf.2001.23.2.627931
Alam, M.A., Islam, M.A., Al Mamun, M.A., Faruk, M., Ul Islam, M.T., Rahman, M.M., et al. (2017) Astaxanthin Ameliorates Hepatic Damage and Oxidative Stress in Carbon Tetrachloride-Administered Rats. Pharmacognosy Research, 9, s84-s91. >https://doi.org/10.4103/pr.pr_26_17
Lee, J.Y. and Hwang, D.H. (2006) The Modulation of Inflammatory Gene Expression by Lipids: Mediation through Toll-Like Receptors. Molecules and Cells, 21, 174-185. >https://doi.org/10.1016/s1016-8478(23)12877-9
Du, L., Zheng, Y., Yang, Y., Huang, Y., Hao, Y., Chen, C., et al. (2022) Krill Oil Prevents Lipopolysaccharide-Evoked Acute Liver Injury in Mice through Inhibition of Oxidative Stress and Inflammation. Food&Function, 13, 3853-3864. >https://doi.org/10.1039/d1fo04136c
Zhang, Z., Guo, C., Jiang, H., Han, B., Wang, X., Li, S., et al. (2020) Inflammation Response after the Cessation of Chronic Arsenic Exposure and Post-Treatment of Natural Astaxanthin in Liver: Potential Role of Cytokine-Mediated Cell-Cell Interactions. Food&Function, 11, 9252-9262. >https://doi.org/10.1039/d0fo01223h
陈金丽. 虾青素对牛黄解毒片所致小鼠肝脏损伤的保护作用及其可能机制[D]: [硕士学位论文]. 沈阳: 中国医科大学, 2018.
Xu, L., Xu, X., Guo, L., Wang, Z., Wu, X., Kuang, H., et al. (2021) Potential Environmental Health Risk Analysis of Neonicotinoids and a Synergist. Environmental Science&Technology, 55, 7541-7550. >https://doi.org/10.1021/acs.est.1c00872
Sarιkaya, R., Sepici-Dinçel, A., Çaǧlan Karasu Benli, A., Selvi, M. and Erkoç, F. (2010) The Acute Toxicity of Fenitrothion on Narrow-Clawed Crayfish (Astacus leptodactylus Eschscholtz, 1823) in Association with Biomarkers of Lipid Peroxidation. Journal of Biochemical and Molecular Toxicology, 25, 169-174. >https://doi.org/10.1002/jbt.20373
Abou-Zeid, S.M., Aljuaydi, S.H., AbuBakr, H.O., Tahoun, E.A., Di Cerbo, A., Alagawany, M., et al. (2021) Astaxanthin Mitigates Thiacloprid-Induced Liver Injury and Immunotoxicity in Male Rats. Marine Drugs, 19, Article 525. >https://doi.org/10.3390/md19090525
Gradelet, S., Astorg, P., Le Bon, A., Bergès, R. and Suschetet, M. (1997) Modulation of Aflatoxin B1 Carcinogenicity, Genotoxicity and Metabolism in Rat Liver by Dietary Carotenoids: Evidence for a Protective Effect of CYP1A Inducers. Cancer Letters, 114, 221-223. >https://doi.org/10.1016/s0304-3835(97)04668-5
Monmeesil, P., Fungfuang, W., Tulayakul, P. and Pongchairerk, U. (2019) The Effects of Astaxanthin on Liver Histopathology and Expression of Superoxide Dismutase in Rat Aflatoxicosis. Journal of Veterinary Medical Science, 81, 1162-1172. >https://doi.org/10.1292/jvms.18-0690
Tian, Y., Che, H., Yang, J., Jin, Y., Yu, H., Wang, C., et al. (2023) Astaxanthin Alleviates Aflatoxin B1-Induced Oxidative Stress and Apoptosis in IPEC-J2 Cells via the Nrf2 Signaling Pathway. Toxins, 15, Article 232. >https://doi.org/10.3390/toxins15030232
Jaurigue, M.M. (2014) Therapy for Alcoholic Liver Disease. World Journal of Gastroenterology, 20, 2143-2158. >https://doi.org/10.3748/wjg.v20.i9.2143
Hosseini, N., Shor, J. and Szabo, G. (2019) Alcoholic Hepatitis: A Review. Alcohol and Alcoholism, 54, 408-416. >https://doi.org/10.1093/alcalc/agz036
Dunn, W. and Shah, V.H. (2016) Pathogenesis of Alcoholic Liver Disease. Clinics in Liver Disease, 20, 445-456. >https://doi.org/10.1016/j.cld.2016.02.004
Yan, J., Nie, Y., Luo, M., Chen, Z. and He, B. (2021) Natural Compounds: A Potential Treatment for Alcoholic Liver Disease? Frontiers in Pharmacology, 12, Article 694475. >https://doi.org/10.3389/fphar.2021.694475
Liu, H., Liu, M., Fu, X., Zhang, Z., Zhu, L., Zheng, X., et al. (2018) Astaxanthin Prevents Alcoholic Fatty Liver Disease by Modulating Mouse Gut Microbiota. Nutrients, 10, Article 1298. >https://doi.org/10.3390/nu10091298